RenovoRx, Inc. Share Price & Technical Analysis
RNXT · $0.93 (+5.68%)
Healthcare / Biotechnology
$0.93
+5.68%
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in…
Price chart
Seasonality
May has 2 positive and 1 negative years (last 5 years shown)
0% return in May, 1% avg return in past 3 year May month.
-6% return in 2026, 42% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 11% | -18% | 11% | -10% | 0% | – | – | – | – | – | – | – | -6% |
| 25 | 8% | -29% | 0% | 0% | 40% | -7% | -8% | -17% | 30% | -15% | -18% | -11% | -27% |
| 24 | -21% | 6% | -24% | -8% | 0% | 0% | 9% | -17% | 10% | -9% | 30% | 8% | -14% |
| 23 | 0% | 74% | -27% | -6% | -37% | 5% | -13% | -20% | -24% | -21% | -45% | 283% | 169% |
| 22 | -31% | 3% | -12% | -41% | 18% | 0% | 0% | 5% | -5% | -5% | 11% | 28% | -30% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$39.12M
P/E ratio
—
52W high
$1.45
52W low
$0.70
Volume
3,40,269
Beta
1.00
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is RenovoRx, Inc. share price today?
- RenovoRx, Inc. (RNXT) last traded around $0.93 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does RNXT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for RNXT. Download the app for real-time alerts.
- How can I analyze RenovoRx, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.